Search

Orest O Olejnik

from Reno, NV
Age ~69
Get Report
Also known as:
Orest L Olejnik, Orest W Olejnik, Forest Olejnik
Phone and address:
6060 Lake Geneva Dr, Reno, NV 89511
Related to:
Eugenia L Olejnik, 91David MedinaJoseph Reilly, 82Lisa Brewer, 57James Brewer, 36David Reilly, 49
Connected to:
Agnieszka Olejnik, 42Alan S Olejnik, 35Edyta Olejnik, 61Elena E Olejnik, 49Jerzy Olejnik, 62Krystyna B Olejnik, 73Loralee R Olejnik, 44Melissa J Olejnik, 54Peter N Olejnik, 74Jan Olek, 73

Orest Olejnik Phones & Addresses

  • 6060 Lake Geneva Dr, Reno, NV 89511
  • Naples, FL
  • Chicago, IL
  • 5 Addington Pl, Trabuco Canyon, CA 92679
  • 16 Brassie Ln, Trabuco Canyon, CA 92679
  • Rancho Santa Margarita, CA
  • Mission Viejo, CA
  • Orange, CA

Work

Position: Precision Production Occupations

Education

Degree: Bachelor's degree or higher

Publications

Us Patents

Preserved Cyclodextrin-Containing Compositions

View page
US Patent:
6358935, Mar 19, 2002
Filed:
Sep 2, 1999
Appl. No.:
09/388968
Inventors:
Gary J. Beck - Fullerton CA
Edward D. S. Kerslake - Newport Beach MA
Orest Olejnik - Coto De Caza CA
Assignee:
Allergan Sales, Inc. - Irvine CA
International Classification:
A61K 31715
US Classification:
514 58, 424 65
Abstract:
Compositions including a liquid medium, a cyclodextrin component and a preservative component which has a reduced tendency to being complexed with the cyclodextrin component. In one embodiment, the preservative component is a chlorite component. Active components, such as pharmaceutically active components or drugs, preferably are included in the compositions.

Implant Device With A Retinoid For Improved Biocompatibility

View page
US Patent:
6455062, Sep 24, 2002
Filed:
Aug 21, 2001
Appl. No.:
09/935360
Inventors:
Orest Olejnik - Coto De Caza CA
Patrick M. Hughes - Aliso Viejo CA
John S. Kent - Newport Beach CA
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61F 200
US Classification:
424423, 424422, 424426
Abstract:
An implant device is provided which incorporates a retinoid for improving the biocompatibility of the device in tissue. The device may be bioerodible for the purpose of systemically or locally releasing a therapeutic agent in tissue or it may be a permanent implant which includes a surface treated with a retinoid for increasing the biocompatibility thereof.

Implant Device With A Retinoid For Improved Biocompatibility

View page
US Patent:
6537568, Mar 25, 2003
Filed:
Oct 17, 2001
Appl. No.:
09/982219
Inventors:
Orest Olejnik - Coto De Caza CA
Patrick M. Hughes - Aliso Viejo CA
John S. Kent - Newport Beach CA
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61F 202
US Classification:
424423, 6048901, 514725
Abstract:
An implant device is provided which incorporates a retinoid for improving the biocompatibility of the device in tissue. The device may be bioerodible for the purpose of systemically or locally releasing a therapeutic agent in tissue or it may be a permanent implant which includes a surface treated with a retinoid for increasing the biocompatibility thereof.

Ophthalmic Compositions Containing Loratadine

View page
US Patent:
6635654, Oct 21, 2003
Filed:
Jan 9, 2003
Appl. No.:
10/340355
Inventors:
Chin-Ming Chang - Tustin TX
Eldon Q. Farnes - Laguna Beach CA
Orest Olejnik - Coto De Caza CA
James N. Chang - Newport Beach CA
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 3144
US Classification:
514290
Abstract:
The present invention is directed to an ophthalmic formulation which comprises a therapeutically effective amount of ethyl 4-(8-chloro-5,6-dihydro-11-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinecarboxylate, known as loratadine, a fatty acid ester, and a surfactant, which has been found to be useful in treating ocular allergies, especially allergic conjunctivitis, and related conditions.

Preserved Cyclodextrin-Containing Compositions

View page
US Patent:
6723353, Apr 20, 2004
Filed:
Nov 20, 2001
Appl. No.:
09/989295
Inventors:
Gary J. Beck - Fullerton CA
Edward D. S. Kerslake - Charlestown MA
Orest Olejnik - Coto de Caza CA
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 3314
US Classification:
424661, 514 58
Abstract:
Compositions including a liquid medium, a cyclodextrin component and a preservative component which has a reduced tendency to being complexed with the cyclodextrin component. In one embodiment, the preservative component is a chlorite component. Active components, such as pharmaceutically active components or drugs, preferably are included in the compositions.

Ophthalmic Compositions Comprising Trefoil Factor Family Peptides

View page
US Patent:
6984628, Jan 10, 2006
Filed:
Jul 15, 2003
Appl. No.:
10/621053
Inventors:
Peter G. Bakhit - Huntington Beach CA, US
Orest Olejnik - Coto De Caza CA, US
Richard Graham - Irvine CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 38/02
A61K 38/17
US Classification:
514 21, 514 2
Abstract:
This invention relates to compositions comprising trefoil family factor peptides which are useful in preventing or treating dry eye by topical administration of the composition to eye of the patient. One aspect of this invention relates to topical ophthalmic compositions comprising a trefoil factor family peptide, and preferably, a mucoadhesive component, as described herein. Another aspect of this invention relates to the use of these compositions to treat or prevent dry eye in a patient.

Cyclosporin Compositions

View page
US Patent:
7202209, Apr 10, 2007
Filed:
Jul 13, 2005
Appl. No.:
11/181428
Inventors:
James N. Chang - Newport Beach CA, US
Orest Olejnik - Coto De Caza CA, US
Bruce A. Firestone - Irvine CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 38/12
US Classification:
514 9, 530317, 514912, 514975, 435112
Abstract:
A composition comprising a therapeutically effective amount of cyclosporin A, a blend of oils having a specific gravity of from 0. 90 to 1. 07, and a surfactant is disclosed herein.

Compositions And Methods Comprising Prostaglandin Related Compounds And Trefoil Factor Family Peptides For The Treatment Of Glaucoma With Reduced Hyperemia

View page
US Patent:
7244768, Jul 17, 2007
Filed:
Aug 25, 2004
Appl. No.:
10/521367
Inventors:
Peter G. Bakhit - Huntington Bech CA, US
Richard Graham - Irvine CA, US
Orest Olejnik - Coto De Caza CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61K 31/165
A61K 31/00
US Classification:
514623, 514 13
Abstract:
Compositions, methods, and pharmaceutical products related to prostaglandin-related compounds and trefoil factor family peptides are disclosed herein. Of particular interest are compositions and methods useful for the treatment of glaucoma with a reduced occurrence of hyperemia.
Control profile
Orest O Olejnik from Reno, NV, age ~69 Get Report